Group One Trading
LEGN icon

Group One Trading’s Legend Biotech LEGN Stock Holding History

Group One Trading’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$772K Sell
26,717
-24,193
-48% -$653K ﹤0.01% 3129
2026
Q1 		$921K Buy
50,910
+10,934
+27% +$208K ﹤0.01% 2802
2025
Q4 		$869K Buy
39,976
+1,268
+3% +$36.3K ﹤0.01% 3019
2025
Q3 		$1.26M Buy
38,708
+26,181
+209% +$967K ﹤0.01% 2781
2025
Q2 		$445K Sell
12,527
-28,905
-70% -$937K ﹤0.01% 3539
2025
Q1 		$1.41M Sell
41,432
-3,599
-8% -$129K ﹤0.01% 2152
2024
Q4 		$1.47M Buy
45,031
+1,891
+4% +$78.3K ﹤0.01% 2197
2024
Q3 		$2.1M Buy
43,140
+14,925
+53% +$795K 0.01% 1677
2024
Q2 		$1.25M Buy
+28,215
New +$1.3M ﹤0.01% 1810
2024
Q1 		– Sell
-2,560
Closed -$154K – 7530
2023
Q4 		$154K Buy
+2,560
New +$162K ﹤0.01% 4100
2023
Q1 		– Sell
-20,206
Closed -$988K – 7593
2022
Q4 		$1.01M Buy
20,206
+11,031
+120% +$534K ﹤0.01% 2401
2022
Q3 		$374K Buy
9,175
+9,108
+13,594% +$428K ﹤0.01% 3511
2022
Q2 		$4K Sell
67
-3,890
-98% -$164K ﹤0.01% 7202
2022
Q1 		$144K Buy
+3,957
New +$156K ﹤0.01% 5136

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Group One Trading's LEGN Position: Q2 2026 in Review

Group One Trading reduced its Legend Biotech (LEGN) stake by 48% in Q2 2026, selling an estimated $653K and leaving 26,717 shares worth $772K. The position accounts for ﹤0.01% of the portfolio, ranked #3129.

Group One Trading first reported a position in LEGN in Q1 2022 and has held it in 14 quarters since. The position peaked at $2.1M in Q3 2024. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Group One Trading held 26,717 shares of Legend Biotech worth $772K as of Q2 2026.
  • Group One Trading sold 24,193 Legend Biotech shares in Q2 2026, an estimated $653K.
  • Legend Biotech made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #3129 holding.
  • Group One Trading first reported a position in Legend Biotech in Q1 2022 and has held it in 14 quarters since.
  • Group One Trading's Legend Biotech position peaked at $2.1M in Q3 2024.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.